跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
注射用替加环素 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Tigecycline for Injection
Approved
化学药品
Tigecycline for Injection
Nanjing King-friend Biochemical Pharmaceutical Co., Ltd.
🇨🇳 National Medical Products Administration
Approval Date
Apr 12, 2022
Approval ID
8FPocQXko12
Company
Nanjing King-friend Biochemical Pharmaceutical Co., Ltd.
Type
化学药品
Approval Details
Approval Id
8FPocQXko12
Approval Number
国药准字H20223221
Generic Name
注射用替加环素
Generic Name En
Tigecycline for Injection
Drug Type
化学药品
Dosage Form
注射剂
Strength
50mg
Reg Date
2022-04-12
Company Name
Nanjing King-friend Biochemical Pharmaceutical Co., Ltd.
Company Address
南京高新开发区MA010-1号地
Production Company Name
Nanjing King-friend Biochemical Pharmaceutical Co., Ltd.
Production Company Address
南京高新技术产业开发区学府路16号
Company Detail Path
/organization/nanjing-king-friend-biochemical-pharmaceutical-co-ltd
Production Company Detail Path
/organization/nanjing-king-friend-biochemical-pharmaceutical-co-ltd
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Apr 12, 2022
Approval ID
8FPocQXko12
Type
化学药品
Back to NMPA Approvals